Your session is about to expire
← Back to Search
Procedure
Catheter ablation with High Power Short Duration RF ablation settings for Atrial Fibrillation (Short-AF Trial)
N/A
Waitlist Available
Led By Edward P Gerstenfeld, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during ablation and up to 12 month follow up assessment
Awards & highlights
Short-AF Trial Summary
This trial will compare the effectiveness of two different types of radiofrequency ablation in treating atrial fibrillation.
Eligible Conditions
- Atrial Fibrillation
Short-AF Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during ablation and up to 12 month follow up assessment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during ablation and up to 12 month follow up assessment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Ablation Duration
Secondary outcome measures
% pulmonary vein pairs isolated with first encirclement
Freedom from Atrial Fibrillation
Maximum esophageal temperature
+10 moreShort-AF Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: High Power Short Duration (HPSD)Experimental Treatment1 Intervention
Group 2 - High power short duration RF
Group II: Standard Catheter SettingsActive Control1 Intervention
Group 1 - Standard RF ablation settings
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Catheter ablation with High Power Short Duration RF ablation settings
2019
N/A
~60
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,495 Total Patients Enrolled
11 Trials studying Atrial Fibrillation
19,064 Patients Enrolled for Atrial Fibrillation
Edward P Gerstenfeld, MDPrincipal InvestigatorChief of Cardiac Electrophysiology
1 Previous Clinical Trials
3,000 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
3,000 Patients Enrolled for Atrial Fibrillation
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger